Spending some time in the sun, getting regular exercise and eating fish may be all you need to reduce your chance of ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Drug rashes can be an unwanted side effect of many medications. Learn which medications can cause these skin reactions.

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing ...

The Company expects to submit a New Drug Application to the Food and Drug Administration in the third quarter of 2025.

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...

To advance this research towards commercialization, Daniel Fologea benefits from an NSF Transform grant for marketed oriented ...

A new drug combination from Corcept Therapeutics, relacorilant, has shown potential in treating platinum-resistant ovarian ...

Real world data show that immunotherapy leads to better overall survival outcomes than chemotherapy in patients with ...